<DOC>
	<DOCNO>NCT00811824</DOCNO>
	<brief_summary>This study test effect exercise dietary change weight reduction biological marker associate breast cancer risk breast cancer survivor Hispanic African descent ( n=45 ) . This randomized , crossover pilot feasibility study test effect 30-minute circuit-based exercise program combine resistance training aerobic exercise conjunction low-fat calorie reduce diet . Participants randomize either immediate 6-months exercise dietary change , delay group begin exercise dietary change program 6-months study begin . Participants immediate group follow additional 6-months order evaluate adherence exercise dietary change recommendation . Participants group exercise neighborhood Curves® facility least 5 time per week six month participate series nutrition education class .</brief_summary>
	<brief_title>Effects Physical Activity Dietary Change Minority Breast Cancer Survivors</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>2170 yr Stage 0IIIa breast cancer No evidence recurrent/metastatic disease Hispanic African descent ( AfricanAmerican Caribbean ) BMI &gt; 25kg/m2 Sedentary Completed surgery , chemotherapy , radiation therapy ≥ 6 month Blood pressure &lt; 140/90 HgbA1C &lt; 8 LDL cholesterol &lt; 150 No uncontrolled comorbidities VO2 max normal EKG change Nonsmoker Evidence recurrent metastatic breast cancer Uncontrolled comorbid illness include , limited , type I diabetes mellitus , type II diabetes mellitus , hypertension , symptomatic congestive heart failure , unstable angina pectoris , claudication , cardiac arrhythmia ; active pulmonary disease ; hypercholesterolemia , neurological condition , ischemic heart disease , cardiac disease , kidney disease , respiration problem , asthma , shortness breath , physical limitation , abnormal thyroid function , active malignancy , except squamous basal cell carcinoma skin ; receive active chemotherapy radiotherapy ; psychiatric illness/social situation would limit compliance study requirement Currently take Herceptin therapy , abnormal echo MUGA postHerceptin therapy Active tobacco use Currently active exercise and/or dietary change weight loss program If participant develops breast cancer recurrence metastasis 12month study period , participation study terminate .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Weight loss</keyword>
	<keyword>Physical activity</keyword>
	<keyword>Dietary change</keyword>
</DOC>